DYRK1A and diabetes mellitus: DYRK1A haploinsufficient mice are characterized by severe glucose intolerance and reduced β-cell mass and proliferation, eventually developing diabetes [32,33], but upregulation of DYRK1A in their β-cells only enhances the phenotype [14,34].